Ligand Pharmaceuticals (LGND) News Today $165.75 -1.31 (-0.78%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$165.78 +0.03 (+0.02%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LGND Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Ellsworth Advisors LLC Makes New Investment in Ligand Pharmaceuticals Incorporated $LGNDSeptember 13 at 6:52 AM | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Large Growth in Short InterestSeptember 11 at 3:38 PM | marketbeat.comBaird Financial Group Inc. Reduces Stock Position in Ligand Pharmaceuticals Incorporated $LGNDSeptember 10 at 3:34 AM | marketbeat.comJacobs Levy Equity Management Inc. Invests $16.53 Million in Ligand Pharmaceuticals Incorporated $LGNDSeptember 9, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Bought by Clark Capital Management Group Inc.September 7, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $190.00 at OppenheimerSeptember 5, 2025 | marketbeat.comInsider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells 467 Shares of StockSeptember 5, 2025 | insidertrades.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High After Analyst UpgradeSeptember 5, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High Following Analyst UpgradeSeptember 5, 2025 | americanbankingnews.comBenchmark Forecasts Strong Price Appreciation for Ligand Pharmaceuticals (NASDAQ:LGND) StockSeptember 4, 2025 | marketbeat.comWhat Analysts Are Saying About Ligand Pharmaceuticals StockSeptember 3, 2025 | benzinga.comLigand Pharmaceuticals Incorporated $LGND Stake Reduced by Ashford Capital Management Inc.September 1, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Acquired by Northern Trust CorpSeptember 1, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Purchased by American Century Companies Inc.September 1, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Reaches New 52-Week High Following Analyst UpgradeAugust 31, 2025 | marketbeat.comNuveen LLC Buys New Stake in Ligand Pharmaceuticals Incorporated $LGNDAugust 29, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of "Buy" from BrokeragesAugust 26, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Bought by CW Advisors LLCAugust 24, 2025 | marketbeat.comInvesco Ltd. Purchases 8,473 Shares of Ligand Pharmaceuticals Incorporated $LGNDAugust 23, 2025 | marketbeat.comA Fresh Look at Ligand Pharmaceuticals (LGND) Valuation Following $400 Million Convertible Note Offering and Capital Structure ShiftAugust 22, 2025 | finance.yahoo.comConnor Clark & Lunn Investment Management Ltd. Reduces Position in Ligand Pharmaceuticals Incorporated $LGNDAugust 22, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Sold by Vanguard Group Inc.August 22, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Bought by Aberdeen Group plcAugust 20, 2025 | marketbeat.comLigand Pharmaceuticals Inc (LGND) Announces Participation in Upcoming Investor Conferences | ...August 19, 2025 | gurufocus.comLigand Pharmaceuticals to Participate in Upcoming Investor Conferences in September 2025August 19, 2025 | quiverquant.comQLigand to Participate in September Investor ConferencesAugust 19, 2025 | globenewswire.comRussell Investments Group Ltd. Has $14.23 Million Stake in Ligand Pharmaceuticals Incorporated $LGNDAugust 19, 2025 | marketbeat.comPublic Sector Pension Investment Board Grows Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)August 18, 2025 | marketbeat.comLigand Pharma Completes $460M Convertible Notes OfferingAugust 14, 2025 | msn.comLigand Announces Closing of Convertible Senior Notes OfferingAugust 14, 2025 | globenewswire.comUS Bancorp DE Purchases 3,301 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)August 14, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High - Should You Buy?August 13, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - Should You Sell?August 12, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Purchased by Townsquare Capital LLCAugust 12, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Insmed (INSM), Ligand Pharma (LGND)August 12, 2025 | theglobeandmail.comLigand Pharmaceuticals to offer $400M convertible senior notes in private placementAugust 12, 2025 | msn.comLGND: Getting In Tune with MedTechAugust 12, 2025 | msn.comLigand prices $400M convertible debt offeringAugust 12, 2025 | msn.comLigand Pharmaceuticals Inc (LGND) Announces Pricing of $400 Million Convertible Senior Notes | ...August 12, 2025 | gurufocus.comLigand Pharmaceuticals Inc (LGND) Announces Pricing of $400 Million Convertible Senior Notes | ...August 12, 2025 | gurufocus.comLigand Pharmaceuticals Prices $400 Million Convertible Senior Notes Due 2030August 11, 2025 | quiverquant.comQLigand Pharmaceuticals prices $400 million convertible notes offeringAugust 11, 2025 | investing.comLigand Announces Pricing of $400 Million Convertible Senior Notes OfferingAugust 11, 2025 | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Expectations By $0.06 EPSAugust 11, 2025 | marketbeat.comLigand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030August 11, 2025 | globenewswire.comRoyal Bank Of Canada Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock PriceAugust 10, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Stock Rating Upgraded by Wall Street ZenAugust 10, 2025 | marketbeat.comLigand (LGND) Q2 Revenue Jumps 15%August 8, 2025 | theglobeandmail.comLigand Pharmaceuticals (NASDAQ:LGND) Updates FY 2025 Earnings GuidanceAugust 8, 2025 | marketbeat.comLigand Pharmaceuticals Inc (LGND) Q2 2025 Earnings Call Highlights: Robust Royalty Growth and ...August 8, 2025 | gurufocus.com Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LGND Media Mentions By Week LGND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LGND News Sentiment▼1.720.92▲Average Medical News Sentiment LGND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LGND Articles This Week▼66▲LGND Articles Average Week Get the Latest News and Ratings for LGND and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Ligand Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ADMA News Today ANIP News Today BMRN News Today EXAS News Today EXEL News Today IONS News Today MDGL News Today HALO News Today RGEN News Today ALKS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LGND) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGND Stock Alerts